Physician profile
Jayne Word
NPI 1003176777
$988.82
in general payments reported to CMS, 2019-2025
14 companies · $372 in 2025
The $372 reported for 2025 was more than what a typical Acute Care (Nurse Practitioner) provider received nationally (typical 2025 total: $151).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $188 · 2023: $274 · 2024: $154 · 2025: $372.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $800.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $800.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $177.05 | 2024-2025 | Puraply Wound Matrix, Puraply Am |
| Edwards Lifesciences Corporation | $145.73 | 2023 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Impulse Dynamics (USA) INC. | $143.35 | 2022 | |
| Mimedx Group, INC. | $133.03 | 2024-2025 | |
| Molnlycke Health Care US, LLC | $80.66 | 2023 | Mepilex Border Flex, Exufiber Ag+, Mepilex Lite |
| Urgo Medical North America, LLC | $77.85 | 2024-2025 | Urgoclean Ag, Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap |
| Hydrofera LLC | $52.00 | 2022-2025 | Hydrofera Blue |
| Abbvie INC. | $34.90 | 2025 | |
| Hartmann USA, INC. | $29.83 | 2024 | Zetuvit Plus 10x10 P10 |
| Coloplast Corp | $26.87 | 2024 | |
| Melinta Therapeutics, LLC | $26.10 | 2023 | Orbactiv, Kimyrsa |
| Paratek Pharmaceuticals, INC. | $21.36 | 2023 | Nuzyra |
| Abbott Laboratories | $20.30 | 2022 | |
| Integra Lifesciences Corporation | $19.79 | 2024 | Tcc-Ez |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jayne Word listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.